On June 1, we finished the 2022 Medtech Innovator road tour 1 minute and 5 minute pitch and Q&A, and received the evaluation contents from the judges.

The first selection result will be announced at the end of June.

We can explain the innovation, marketability, and potential of Anyfusion through e-mail and video call about the deficiencies of the pitch process with those who reviewed additionally.

Unlike domestic IR (Corporate Briefing), the reasonable way to share and communicate with the affiliates and contacts of the judges is being conducted in a completely different way than in Korea.

As we have experienced in Korea, Anyfusion is the world's first technology, overcoming many problems of existing products (real-time accuracy, free flow, start-up delay, carelessness, workload, etc.) with original technology, and is the ideal medical, clinical, and safety injection pump.

We can make them accurately understand our excellence without seeing the actual operation, function, performance, etc. through on and off line meeting that the cylinder-type drug injection pump is the world’s first Whole in one function, such as PCA pump and Blood transmission pump function.

In addition, our ACPi system is the world's first general-purpose anticancer (injection) manufacturing system with a high cost-effectiveness of more than 95% including more than 100 to 300 preparations per day and the most toxic 5FU anticancer drugs that robots cannot prepare by robots.

This is the road tour of the accelerator system with rationality to appeal our technology and products through on and off-line meetings, introducing the technologies and characteristics like as PCA ballon filling and pollution prevention of general medicine preparation without syringes and Whole in one APiS.

Company N, the world-class company that participated in the screening, shared our products with company officials and decided to communicate.

If we have a chance, we will visit them and explain our products directly or through an exhibition, so that we can proceed with the developmental global business with Company N.

I would like to thank the judges who participated in the screening and Medtech officials for their hard work on the road tour.

Thank you.